Breast cancer Trials in Fort Smith, United States
Conditions / Breast cancer / Fort Smith, United States
Breast cancer has been the subject of sustained clinical investigation across multiple research sites.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | COMPLETED | PHASE3 |
| NCT00041119 | Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer | COMPLETED | PHASE3 |
| NCT00075764 | S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer | COMPLETED | PHASE3 |
| NCT05896189 | Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors | RECRUITING | — |
| NCT00070564 | S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00316836 | Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole | COMPLETED | — |
| NCT02032823 | Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03662204 | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | COMPLETED | — |
| NCT06748222 | E-Mindfulness Approaches for Living After Breast Cancer | RECRUITING | — |
| NCT05879926 | Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 | RECRUITING | — |